中华胃肠外科杂志
中華胃腸外科雜誌
중화위장외과잡지
CHINESE JOURNAL OF GASTROINTESTINAL SURGERY
2012年
1期
47-50
,共4页
邱辉忠%肖毅%林国乐%吴斌%牛备战%周皎琳
邱輝忠%肖毅%林國樂%吳斌%牛備戰%週皎琳
구휘충%초의%림국악%오빈%우비전%주교림
直肠肿瘤,低位%经前会阴超低位直肠前切除术%肛门功能
直腸腫瘤,低位%經前會陰超低位直腸前切除術%肛門功能
직장종류,저위%경전회음초저위직장전절제술%항문공능
Rectal neoplasms,low%Anterior perineal plane for ultra-low anterior resection of the rectum%Anal function
目的 总结经前会阴超低位直肠前切除术(APPEAR)治疗低位直肠癌的临床经验.方法 回顾性分析2009年9月至2011年8月间在北京协和医院基本外科施行APPEAR手术的26例低位直肠癌患者的临床和随访资料.结果 26例患者中男19例,女7例,年龄(63.4±9.5)岁.术前检查见肿瘤距肛缘距离(4.6±0.7) cm,14例患者术前接受新辅助放化疗.26例患者均顺利保肛,手术时间(170±21) min,术中出血量(140±69) ml.术中发生直肠破损1例,术后发生会阴切口感染4例.术后病理:高中分化腺癌10例,中分化腺癌伴部分黏液腺癌7例,低分化腺癌1例,绒毛状腺瘤高级别上皮内瘤变1例,直肠绒毛状腺瘤1例,标本未找到癌细胞6例.术后全组均获随访,随访时间(11.4±5.6)个月,随访期间未出现泌尿功能障碍和肿瘤复发.18例患者于术后6个月行横结肠造口还纳术,术后Wexner控粪功能评分平均为5.5分.肛门直肠功能测压显示,肛门括约肌最大主动收缩压为(224.0±59.3) mm Hg,肛门括约肌最大静息压为(42.5±11.8) mm Hg,直肠最大耐受量为(120.0±27.4) ml,直肠肛门抑制反射均存在.结论 经前会阴超低位直肠前切除术适用于部分保留肛门的低位直肠癌手术,并能取得较为满意的肛门排粪功能.
目的 總結經前會陰超低位直腸前切除術(APPEAR)治療低位直腸癌的臨床經驗.方法 迴顧性分析2009年9月至2011年8月間在北京協和醫院基本外科施行APPEAR手術的26例低位直腸癌患者的臨床和隨訪資料.結果 26例患者中男19例,女7例,年齡(63.4±9.5)歲.術前檢查見腫瘤距肛緣距離(4.6±0.7) cm,14例患者術前接受新輔助放化療.26例患者均順利保肛,手術時間(170±21) min,術中齣血量(140±69) ml.術中髮生直腸破損1例,術後髮生會陰切口感染4例.術後病理:高中分化腺癌10例,中分化腺癌伴部分黏液腺癌7例,低分化腺癌1例,絨毛狀腺瘤高級彆上皮內瘤變1例,直腸絨毛狀腺瘤1例,標本未找到癌細胞6例.術後全組均穫隨訪,隨訪時間(11.4±5.6)箇月,隨訪期間未齣現泌尿功能障礙和腫瘤複髮.18例患者于術後6箇月行橫結腸造口還納術,術後Wexner控糞功能評分平均為5.5分.肛門直腸功能測壓顯示,肛門括約肌最大主動收縮壓為(224.0±59.3) mm Hg,肛門括約肌最大靜息壓為(42.5±11.8) mm Hg,直腸最大耐受量為(120.0±27.4) ml,直腸肛門抑製反射均存在.結論 經前會陰超低位直腸前切除術適用于部分保留肛門的低位直腸癌手術,併能取得較為滿意的肛門排糞功能.
목적 총결경전회음초저위직장전절제술(APPEAR)치료저위직장암적림상경험.방법 회고성분석2009년9월지2011년8월간재북경협화의원기본외과시행APPEAR수술적26례저위직장암환자적림상화수방자료.결과 26례환자중남19례,녀7례,년령(63.4±9.5)세.술전검사견종류거항연거리(4.6±0.7) cm,14례환자술전접수신보조방화료.26례환자균순리보항,수술시간(170±21) min,술중출혈량(140±69) ml.술중발생직장파손1례,술후발생회음절구감염4례.술후병리:고중분화선암10례,중분화선암반부분점액선암7례,저분화선암1례,융모상선류고급별상피내류변1례,직장융모상선류1례,표본미조도암세포6례.술후전조균획수방,수방시간(11.4±5.6)개월,수방기간미출현비뇨공능장애화종류복발.18례환자우술후6개월행횡결장조구환납술,술후Wexner공분공능평분평균위5.5분.항문직장공능측압현시,항문괄약기최대주동수축압위(224.0±59.3) mm Hg,항문괄약기최대정식압위(42.5±11.8) mm Hg,직장최대내수량위(120.0±27.4) ml,직장항문억제반사균존재.결론 경전회음초저위직장전절제술괄용우부분보류항문적저위직장암수술,병능취득교위만의적항문배분공능.
Objective To summarize clinical experience in the treatment of low rectal cancer with anterior perineal plane for ultra-low anterior resection of the rectum (APPEAR).Methods Clinical and follow-up data of 26 patients with low rectal cancer undergoing the APPEAR operation in Department of General Surgery at Peking Union Medical College from September 2009 to August 2011 were retrospectively analyzed.Results The 26 cases consisted of 19 male and 7 female patients with an average age of (63.4±9.5) years.The average tumor distance from the anal verge was (4.6±0.7) cm according to preoperative examinations. Fourteen patients received neoadjuvant radiochemotherapy before the operation. All the 26 patients had successful sphincter-preserving operations. The average operative time was (170±21) min and the average intra-operative blood loss (140±69) ml.Complications included one case of intraoperative injury to the rectal wall and 4 cases of postoperative perineal wound infection.Postoperative pathological examination showed well to moderately differentiated adenocarcinomas (n=10),moderately differentiated adenocarcinomas with partial mucinous adenocarcinomas (n =7),poorly differentiated adenocarcinoma (n =1 ),villous adenoma with high-grade intraepithelial neoplasia (n=l),and rectal villous adenoma (n=1).In 6 cases no residual tumor cells were detected in the surgical specimens.All the patients were followed-up for an average period of (11.4±5.6) months.No impaired urinary function or tumor recurrence was observed during the follow-up.Eighteen patients had the transverse colon stoma closure six months after the operation.The average Wexner continence score was 5.5 after colostomy reversal surgery.The anorectal manometry tests showed that maximum squeeze pressure of the anal sphincter was(224.0±59.3) mm Hg.The maximum resting pressure was (42.5±11.8) mm Hg,and the maximum tolerable volume of the rectum was (120.0±27.4) ml.Anorectal reflexes were present in all these patients.Conclusion The APPEAR technique can be applied in the sphincter-preserving operations for low rectal cancer patients with satisfactory anal function.